ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2351-2357

  Wu, Guojun ^a   Nomoto, Shuji ^a   Hoque, Mohammad Obaidul ^a   Dracheva, Tatiana ^b   Osada, Motonabu ^a   Lee, Chyi Chia Richard ^a   Dong, Seung Myung ^a   Guo, Zhongmin ^a   Benoit, Nicole ^a   Cohen, Yoram ^a   Rechthand, Peggy ^a   Califano, Joseph ^a   Moon, Chul So ^a   Ratovitski, Edward ^a   Jen, Jin ^b   Sidransky, David ^a   Trink, Barry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN P63; CKAP4 PROTEIN, HUMAN; DNA BINDING PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PROTEIN P53; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE P63; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; BIOSYNTHESIS; BONE TUMOR; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN;

APOPTOSIS; BONE NEOPLASMS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; PHOSPHOPROTEINS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SKIN; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0037507296     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90: 809-819. 1997.
2. Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J., and Sidransky, D. A new human p53 homologue. Nat. Med., 4: 747-748, 1998.
3. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru. R., Katoh. I., Ikawa, Y., Nimura, Y., Nakagawara. A., Obinata, M., and Ikawa, S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med., 4: 839-843, 1998.
4. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D., and McKeon, F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2: 305-316, 1998.
5. Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., McKeon, F., and Caput, D. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (Lond.), 404: 99-103. 2000.
6. Yamaguchi, K, Wu, L., Caballero, O. L., Hibi, K., Trink, B., Resto, V., Cairns, P., Okami, K., Koch, W. M., Sidransky, D., and Jen, J. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int. J. Cancer, 86: 684-689, 2000.
7. Chi, S. W., Ayed, A., and Arrowsmith, C. H. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J., 18: 4438-4445, 1999.
8. Stiewe, T., Zimmermann, S., Frilling, A., Esche, H., and Putzer, B. M. Transactivation-deficient ΔTA-p73 acts as an oncogene. Cancer Res., 62: 3598-3602, 2002.
9. Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., and Moll, U. M. ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med., 196: 765-780, 2002.
10. Ratovitski, E. A., Patturajan, M., Hibi, K., Trink, B., Yamaguchi, K., and Sidransky, D. p53 associates with and targets ΔNp63 into a protein degradation pathway. Proc. Natl. Acad. Sci. USA, 98: 1817-1822, 2001.
11. Hibi, K., Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratovitski. E. A., Jen, J., and Sidransky, D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 97: 5462-5467, 2000.
12. Patturajan, M., Nomoto, S., Sommer, M., Fomenkov. A., Hibi, K., Zangen, R., Poliak, N., Califano, J., Trink, B., Ratovitski, E., and Sidransky, D. ΔNp63 induces β-catenin nuclear accumulation and signaling. Cancer Cell, 1: 369-379, 2002.
13. Wu, G. J., Sinclair, C. S., Paape, J., Ingle, J. N., Roche, P. C., James. C. D., and Couch, F. J. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res., 60: 5371-5375, 2000.
14. Nylander, K., Coates, P. J., and Hall, P. A. Characterization of the expression pattern of p63α and ΔNp63α in benign and malignant oral epithelial lesions. Int. J. Cancer, 87: 368-372, 2000.
15. Park, B. J., Lee, S. J., Kim, J. I., Lee, C. H., Chang, S. G., Park, J. H., and Chi, S. G. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res, 60: 3370-3374, 2000.
16. Parsa, R., Yang, A., McKeon, F., and Green, H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Investig. Dermatol., 113: 1099-1105, 1999.
17. Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G. M., and Green, D. R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol., 2: 469-475, 2000.
18. Hayward, B. E., and Bonthron, D. T. Structure and alternative splicing of the ketohexokinase gene. Eur. J. Biochem., 257: 85-91, 1998.
19. Stokes, D. G., Saitta, B., Timpl, R., and Chu, M. L. Human α 3(VI) collagen gene. Characterization of exons coding for the amino-terminal globular domain and alternative splicing in normal and tumor cells. J. Biol. Chem., 266: 8626-8633, 1991.
20. Kawashima, I., Ohsumi, J., Mita-Honjo, K., Shimoda-Takano, K., Ishikawa, H., Sakakibara, S., Miyadai, K., and Takiguchi, Y. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett., 283: 199-202, 1991.
21. Kataoka, K., Noda, M., and Nishizawa, M. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos, and small Maf proteins. Oncogene, 12: 53-62, 1996.
22. Licht, J. D. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene, 20: 5660-5679, 2001.
23. Xie, K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev., 12: 375-391, 2001.
24. Brandt, E., Petersen, F., Ludwig, A., Ehlert, J. E., Bock, L., and Flad, H. D. The β-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J. Leukoc. Biol., 67: 471-478, 2000.
25. Li, Y., He, X., Schembri-King, J., Jakes, S., and Hayashi, J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J. Immunol., 164: 5199-5206, 2000.
26. Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., and Tsai, L. H. A family of human cdc2-related protein kinases. EMBO J., 11: 2909-2917, 1992.
27. Okuda, T., Valentine, V. A., Shapiro, D. N., and Downing, J. R. Cloning of genomic loci and chromosomal localization of the human PCTAIRE-1 and -3 protein kinase genes. Genomics, 21: 217-221, 1994.
28. Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., and Tokino, T. The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem., 277: 719-724, 2002.
29. Zorn, A. M. Wnt signalling: antagonistic Dickkopfs. Curr. Biol., 11: R592-R595, 2001.
30. Wang, J. Y. Regulation of cell death by the Abl tyrosine kinase. Oncogene, 19: 5643-5650, 2000.
31. Curran, T., and Franza, B. R., Jr. Fos and Jun: the AP-1 connection. Cell, 55: 395-397, 1988.
32. Elkeles, A., Juven-Gershon, T., Israeli, D., Wilder, S., Zalcenstein, A., and Oren, M. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol. Cell. Biol., 19: 2594-2600, 1999.
33. Contente, A., Dittmer, A., Koch, M. C., Roth, J., and Dobbelstein, M. A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat. Genet., 30: 315-320, 2002.
34. Helmlinger, G., Endo, M., Ferrara, N., Hlatky, L., and Jain, R. K. Formation of endothelial cell networks. Nature (Lond.), 405: 139-141. 2000.
35. Senoo, M., Matsumura, Y., and Habu, S. TAp63γ (p51A) and dNp63α (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. Oncogene, 21: 2455-2465, 2002.
36. Till, K. J., Zuzel, M., and Cawley, J. C. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues. Cancer Res., 59: 4419-4426, 1999.
37. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature (Lond.), 398: 714-718, 1999.
38. Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R., and Bradley, A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (Lond.), 398: 708-713, 1999.
39. Langbein, L., Rogers, M. A., Winter, H., Praetzel, S., Beckhaus, U., Rackwitz, H. R., and Schweizer, J. The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. J. Biol. Chem., 274: 19874-19884, 1999.
40. Takahashi, K., Paladini, R. D., and Coulombe, P. A. Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J. Biol. Chem., 270: 18581-18592, 1995.
41. Guo, L., Degenstein, L., Dowling, J., Yu, Q. C., Wollmann, R., Perman, B., and Fuchs, E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell, 81: 233-243, 1995.
42. Wilkie, A. O., and Morriss-Kay, G. M. Genetics of craniofacial development and malformation. Nat. Rev. Genet., 2: 458-468, 2001.
43. Li, C., Guo, H., Xu, X., Weinberg, W., and Deng, C. X. Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning. Dev. Dyn., 222: 471-483, 2001.
44. Grun, F., Hirose, Y., Kawauchi, S., Ogura, T., and Umesono, K. Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development. J. Biol. Chem., 275: 41210-41218, 2000.
45. Niles, R. M. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition, 16: 1100-1101, 2000.
46. Okamura, S., Ng, C. C., Koyama, K., Takei, Y., Arakawa, H., Monden, M., and Nakamura, Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol. Res., 11: 281-285, 1999.
47. Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., and Vogelstein, B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA, 96: 14517-14522, 1999.
48. Wang. L., Wu, Q., Qiu, P., Mirza, A., McGuirk, M., Kirschmeier, P., Greene, J. R., Wang, Y., Pickett, C. B., and Liu, S. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem., 276: 43604-43610, 2001.
49. Dohn, M., Zhang, S., and Chen, X. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene, 20: 3193-3205, 2001.